Product Information
DULOXETINE HCL DR 60 MG CAP is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1127 per EA under NDC 33342016207. Its NADAC has been published 300 times since Aug 21, 2019.
FDA first approved this application on Mar 23, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342016207
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
DULOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204815FDA Approved
3/23/2017
TE Code
AB
On Market Since
3/24/2017
Pharmacological Classes
Price Statistics
The NADAC for DULOXETINE HCL DR 60 MG CAP has been published 300 times since Aug 21, 2019, and over the history we have for it it has declined 34.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1127 per EA |
|---|---|
| All-time high | $0.1756 (Dec 11, 2019) |
| All-time low | $0.0840 (Nov 20, 2024) |
| Median price | $0.1170 |
| Average price | $0.1284 |
| Largest weekly change | -22.1% (Nov 17, 2021) |
| Weeks tracked | 300 |
| Tracking since | Aug 21, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+0.2%
5Y
-14.2%
All
-34.1%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Duloxetine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DULOXETINE HCL DR 60 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 60 MG CAP, manufactured by Macleods Pharmaceuticals Limited, is $0.1127 per EA (NDC 33342016207), effective May 14, 2025.
How has the price of DULOXETINE HCL DR 60 MG CAP changed over time?
Over the history we have for it, the NADAC for DULOXETINE HCL DR 60 MG CAP has declined 34.1%. It has been tracked across 300 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 60 MG CAP?
Since Aug 21, 2019, the NADAC for DULOXETINE HCL DR 60 MG CAP has ranged from a low of $0.0840 (Nov 20, 2024) to a high of $0.1756 (Dec 11, 2019), with a median of $0.1170 per EA.
Are there cheaper alternatives to DULOXETINE HCL DR 60 MG CAP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DULOXETINE HCL DR 60 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DULOXETINE HCL DR 60 MG CAP?
DULOXETINE HCL DR 60 MG CAP (NDC 33342016207) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.